Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Strain of MRSA from cattle

Scientists find evidence of livestock-to-human transmission

New research has revealed that a type of Methicillin-resistant Staphylococcus aureus (MRSA) found in humans originated in cattle at least 40 years ago.

Scientists based at the University of Edinburgh's Roslin Institute looked at the genetic make-up of more than 40 strains of Staphylococcus aureus, which can build up antibiotic resistance and develop into MRSA.

They found that at least two genetic subtypes of the bacterium can be traced back to cattle – most likely as a result of direct contact from humans working with farm animals, according to the scientists.

When this bacterium became present in humans, it grew resistant to the antibiotic methicillin, therefore developing into MRSA.

The results show clear evidence that livestock was the original source of a type of MRSA that is now widespread in humans. However, scientists say it does not appear any more aggressive or resistant than other forms.

It is hoped that the study will help reveal how bacteria is able to spread and cause disease in humans, thus helping to prevent it from happening in the future.

Lead researcher, Professor Ross Fitzgerald, said: "Human infections caused by bacteria being transmitted directly from livestock are well known to occur, however, this is the first clear genetic evidence of subtypes of Staphylococcus aureus, which jumped from cattle and developed the capacity to transmit widely among human populations."

The study has been published in the mBio journal.

Related News
Development for anthrax and MRSA treatment
Research into antibiotic-resistant E. coli

Become a member or log in to add this story to your CPD history

Greyhound Board announces change to vaccination guidance

News Story 1
 The Greyhound Board of Great Britain has published new vaccination guidance, with all greyhounds registered from 1 January, 2027 required to have the L4 leptospirosis vaccination, rather than L2.

The change comes in response to the reduced availability of the 'L2' Leptospirosis vaccine across the UK, and aims to support best biosecurity practice across the racing greyhound population.

GBGB veterinary director Simon Gower, said "While rare, Leptospirosis is a serious infectious disease that can affect both dogs and humans, so it is vital that we offer our greyhounds the broadest possible protection.  

Click here for more...
News Shorts
Free webinar explores congenital heart disease in dogs

A free webinar is to provide veterinary professionals, dog breeders and pet owners an new insights into congenital heart disease.

Chris Linney, a cardiology specialist and Veterinary Cardiovascular Society (VSC) member, will present the webinar from 7.00pm to 8.30pm on Wednesday, 12 November.

Dr Linney will explore the types, causes and clinical presentation of congenital heart conditions. This will include diagnostic approaches, treatment pathways and emerging research opportunities.

The session is the third to be organised by The Kennel Club, with the VCS, following an introductory webinar and a talk on acquired heart disease. Dr Linney's webinar consists of a one-hour presentation, followed by a 30-minute question and answer session.

Dr Linney said: "This webinar will be an opportunity to deepen understanding - not just of the diseases themselves, but of how breeders, vets and owners can work together to support affected dogs and improve outcomes for future generations."

Click here to register for the webinar.